| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Feb―09 |
Endothelial extracellular vesicles enriched in microRNA-34a predict new-onset diabetes in COVID-19 patients: novel insights for long-COVID metabolic sequelae |
Pasquale Mone, Stanislovas S. Jankauskas, Maria Virginia Manzi, Jessica Gambardella, Antonietta Coppola, Urna Kansakar, et al. (+7) Raffaele Izzo, Giuseppe Fiorentino, Angela Lombardi, Fahimeh Varzideh, Daniela Sorriento, Bruno Trimarco, Gaetano Santulli |
| 2 |
[GO] |
2023―Apr―27 |
Modulation of the immune response to SARS-CoV-2 vaccination by NSAIDs |
Carsten Skarke, Ronan Lordan, Kayla Barekat, Amruta Naik, Divij Mathew, Takuya Ohtani, et al. (+13) Allison R Greenplate, Gregory R Grant, Nicholas F Lahens, Sigrid Gouma, Elizabeth Troisi, Arjun Sengupta, Aalim M Weljie, Wenzhao Meng, Eline T Luning Prak, Kendall Lundgreen, Paul Bates, Hu Meng, Garret A. FitzGerald |
| 3 |
[GO] |
2022―Jul―03 |
Cardiovascular implications of miRNAs in COVID-19 |
Carmine Izzo, Valeria Visco, Jessica Gambardella, Germano Junior Ferruzzi, Antonella Rispoli, Maria Rosaria Rusciano, et al. (+7) Anna Laura Toni, Nicola Virtuoso, Albino Carrizzo, Paola Di Pietro, Guido Iaccarino, Carmine Vecchione, Michele Ciccarelli |
| 4 |
[GO] |
2022―Jun―30 |
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 |
Jessica Gambardella, Urna Kansakar, Celestino Sardu, Vincenzo Messina, Stanislovas S. Jankauskas, Raffaele Marfella, et al. (+6) Paolo Maggi, Xujun Wang, Pasquale Mone, Giuseppe Paolisso, Daniela Sorriento, Gaetano Santulli |
| 5 |
[GO] |
2022―Mar―26 |
L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic |
Pasquale Mone, Raffaele Izzo, Giuseppe Marazzi, Maria Virginia Manzi, Paola Gallo, Giuseppe Campolongo, et al. (+6) Luca Cacciotti, Domenico Tartaglia, Giuseppe Caminiti, Fahimeh Varzideh, Gaetano Santulli, Valentina Trimarco |
| 6 |
[GO] |
2021―Jul―12 |
Cationic Compounds with SARS-CoV-2 Antiviral Activity and their Interaction with OCT/MATE Secretory Transporters. |
Lucy Jazmin Martinez Guerrero, Xiaohong Zhang, Kimberley M. Zorn, Sean Ekins, Stephen H. Wright |
| 7 |
[GO] |
2021―May―10 |
Viral Proteases as Targets for COVID-19 Drug Development |
Wei Zhu, Zeenat A Shyr, Donald C. Lo, Wei Zheng |
| 8 |
[GO] |
2021―Mar―05 |
COVID-19 drugs chloroquine and hydroxychloroquine, but not azithromycin and remdesivir, block hERG potassium channels |
Mark Szendrey, Jun Guo, Wentao Li, Tonghua Yang, Shetuan Zhang |
| 9 |
[GO] |
2020―Oct―28 |
A Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the COVID-19 Pandemic |
Kelly A. Fader, Jiangwei Zhang, Joseph P. Menetski, Ravi I. Thadhani, Elliott M. Antman, Gary S. Friedman, et al. (+2) Shashi K. Ramaiah, Vishal S. Vaidya |
| 10 |
[GO] |
2020―Oct―08 |
The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19 |
Ali Ehsan Sifat, Saeideh Nozohouri, Heidi Villalba, Bhuvaneshwar Vaidya, Thomas J. Abbruscato |
| 11 |
[GO] |
2020―Oct―02 |
Role of GILZ in the Kidney and the Cardiovascular System: Relevance to Cardiorenal Complications of COVID-19 |
Mahmood Mozaffari |
| 12 |
[GO] |
2020―Jul―29 |
Drug discovery strategies for SARS-CoV-2 |
Zeenat A Shyr, Kirill Gorshkov, Catherine Z Chen, Wei Zheng |
|
